Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants
- PMID: 29019701
- DOI: 10.1164/rccm.201708-1605LE
Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants
Comment in
-
Reply to Kovesi, to Chabra, and to Farber: "Palivizumab Prophylaxis and Recurrent Wheezing" and "Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants" and "Imbalance in Level of Tobacco Smoke Exposure Between Groups Likely Explains the "Effect" of Palivizumab on Subsequent Wheezing".Am J Respir Crit Care Med. 2018 Mar 1;197(5):681-682. doi: 10.1164/rccm.201709-1894LE. Am J Respir Crit Care Med. 2018. PMID: 29019699 No abstract available.
Comment on
-
Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.Am J Respir Crit Care Med. 2017 Jul 1;196(1):29-38. doi: 10.1164/rccm.201609-1812OC. Am J Respir Crit Care Med. 2017. PMID: 28152315
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
